Directors' Holdings

MemberShares
12/31/2019
Options
 12/31/2019
Dr Gerd Zettlmeissl, Chairman of Supervisory Board00
Antoinette Hiebeler-Hasner00
Dr Yita Lee00
Prof Dr Horst Domdey39,1250
Dr Keith Manchester1)00
Ronald Scott 00
Dr Frank Mathias 20,19746,0892)
Total Supervisory Board59,32246,089
Prof Dr Dolores J. Schendel, Chief Executive Officer and Chief Scientific Officer 3)846,29687,500
Dr Kai Pinkernell, member of the board063,438
Axel Sven Malkomes, member of the board (from 1 April 2019)065,000
Total Executive Management Board846,296215,938
1) Dr. Manchester is a partner and Head of Life Sciences QVT Financial LP New York, USA.  According to the latest voting rights announcement dated June 8, 2018, the funds managed by QVT hold 1,072,879 shares in Medigene AG.
2) The stated number of options corresponds to 124,839 options prior to a capital reduction in 2013.
3) Prof. Schendel indirectly holds 846,296 Medigene shares in her capacity as Managing Director of DJSMontana Holding GmbH, which can be allocated to Prof. Schendel directly.